Isthmus Partners LLC Has $197,000 Holdings in Core Laboratories Inc. (NYSE:CLB)

Isthmus Partners LLC increased its position in Core Laboratories Inc. (NYSE:CLB) by 18.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,620 shares of the oil and gas company’s stock after acquiring an additional 1,682 shares during the quarter. Isthmus Partners LLC’s holdings in Core Laboratories were worth $197,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Core Laboratories by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 5,392,034 shares of the oil and gas company’s stock worth $92,096,000 after acquiring an additional 27,701 shares during the period. Disciplined Growth Investors Inc. MN raised its holdings in Core Laboratories by 446.8% in the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company’s stock worth $90,508,000 after acquiring an additional 3,644,963 shares during the period. Envestnet Asset Management Inc. raised its holdings in Core Laboratories by 12.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 306,287 shares of the oil and gas company’s stock worth $6,215,000 after acquiring an additional 34,149 shares during the period. Earnest Partners LLC raised its holdings in Core Laboratories by 6.3% in the 2nd quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after acquiring an additional 195,756 shares during the period. Finally, Headlands Technologies LLC bought a new position in Core Laboratories in the 2nd quarter worth $36,000. Institutional investors own 97.81% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Citigroup dropped their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a report on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $17.00.

Core Laboratories Stock Performance

NYSE:CLB opened at $20.37 on Friday. The firm’s 50-day moving average is $19.46 and its 200-day moving average is $19.53. Core Laboratories Inc. has a 52-week low of $13.82 and a 52-week high of $25.13. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48. The company has a market cap of $956.37 million, a price-to-earnings ratio of 31.34, a PEG ratio of 1.37 and a beta of 2.35.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. The business had revenue of $134.40 million for the quarter, compared to analysts’ expectations of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.22 earnings per share. Equities research analysts anticipate that Core Laboratories Inc. will post 0.8 earnings per share for the current year.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 4th were paid a $0.01 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.20%. Core Laboratories’s payout ratio is currently 6.15%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.